Jake Fillery is an Evergreen Editor for GameRant who has been writing lists, guides, and reviews since 2022. With thousands of engaging articles and guides, Jake loves conversations surrounding all ...

For decades, scientists have understood that plants can release volatile organic compounds—essentially airborne chemical signals—to attract the natural enemies of the things that eat them, like ...

It’s been three-and-a-half years since generative AI exploded onto the scene. In this past year, progress has continued its relentless pace: Vibe coding took off, companies embraced agentic workflows, ...

Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based Circulating Tumor DNA Assays, Version 2.0 QCS-derived continuous spatial proximity score (cSPS) and density of ...

The CONVERGE study: A phase II, single-arm trial of adebelimab combined with targeted therapy and liposomal irinotecan-based chemotherapy for conversion surgery in unresectable MSS colorectal cancer ...

A simple explanation of how alcohol interacts with GABA receptors in the brain, which can contribute to feelings of relaxation, slowed activity, and sleepiness. Trump says Iran shot down US helicopter ...

Different receptors respond to different neurotransmitters or hormones, such as adrenaline involved in the fight-or-flight response, or dopamine linked to reward and motivation. Both the receptors ...

Please provide your email address to receive an email when new articles are posted on . Areas of the brain with the GLP-1 receptor are connected to motivational circuits involved in salience and ...

When the IBM PC was new, I served as the president of the San Francisco PC User Group for three years. That’s how I met PCMag’s editorial team, who brought me on board in 1986. In the years since that ...

Findings seen in patients undergoing abdominal panniculectomy. (HealthDay News) — Glucagon-like peptide-1 (GLP-1) receptor agonist (RA) use is associated with delayed wound healing in patients ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and obesity. GLP-1 receptor ...